3.9 Article

Complementary feeding with fortified spread and incidence of severe stunting in 6-to 18-month-old rural Malawians

Journal

ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
Volume 162, Issue 7, Pages 619-626

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/archpedi.162.7.619

Keywords

-

Categories

Funding

  1. NIDDK NIH HHS [P30 DK056341-07, P30 DK056341, P30 DK056341-08] Funding Source: Medline

Ask authors/readers for more resources

Objective: To compare growth and incidence of malnutrition in infants receiving long-term dietary supplementation with ready-to-use fortified spread (FS) or micronutrient-fortified maize-soy flour (likuni phala [LP]). Design: Randomized, controlled, single-blind trial. Setting: Rural Malawi. Participants: A total of 182 six-month-old infants. Intervention: Participants were randomized to receive 1 year of daily supplementation with 71 g of LP (282 kcal), 50 g of FS (FS50) (256 kcal), or 25 g of FS (FS25) (127 kcal). Outcome Measures: Weight and length gains and the incidences of severe stunting, underweight, and wasting. Results: Mean weight and length gains in the LP, FS50, and FS25 groups were 2.37, 2.47, and 2.37 kg (P = .66) and 12.7, 13.5, and 13.2 cm (P = .23), respectively. In the same groups, the cumulative 12-month incidence of severe stunting was 13.3%, 0.0%, and 3.5% (P = .01), of severe underweight was 15.0%, 22.5%, and 16.9% (P = .71), and of severe wasting was 1.8%, 1.9%, and 1.8% P >. 99). Compared with LP-supplemented infants, those given FS50 gained a mean of 100 g more weight and 0.8 cm more length. There was a significant interaction between baseline length and intervention (P = .04); in children with below-median length at enrollment, those given FS50 gained a mean of 1.9 cm more than individuals receiving LP. Conclusion: One-year-long complementary feeding with FS does not have a significantly larger effect than LP on mean weight gain in all infants, but it is likely to boost linear growth in the most disadvantaged individuals and, hence, decrease the incidence of severe stunting. Trial Registration: clinicaltrials.govIdentifier: NCT00131209.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available